DS
ORIC icon

DRW Securities’s Oric Pharmaceuticals ORIC Stock Holding History

DRW Securities’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$155K Buy
+14,312
New +$130K ﹤0.01% 833
2026
Q1 		– Sell
-19,194
Closed -$157K – 1612
2025
Q4 		$157K Buy
+19,194
New +$221K ﹤0.01% 1014

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

DRW Securities's ORIC Position: Q2 2026 in Review

DRW Securities opened a new position in Oric Pharmaceuticals (ORIC) in Q2 2026: 14,312 shares worth $155K. The stake represents ﹤0.01% of the portfolio and ranks #833 among its holdings. This is a return to the name: DRW Securities previously reported a position in ORIC as recently as Q4 2025.

DRW Securities first reported a position in ORIC in Q4 2025 and has held it in 2 quarters since. The position peaked at $157K in Q4 2025. 180 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

  • DRW Securities held 14,312 shares of Oric Pharmaceuticals worth $155K as of Q2 2026.
  • Oric Pharmaceuticals was a new DRW Securities position in Q2 2026.
  • Oric Pharmaceuticals made up ﹤0.01% of DRW Securities's portfolio in Q2 2026, its #833 holding.
  • DRW Securities first reported a position in Oric Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • DRW Securities's Oric Pharmaceuticals position peaked at $157K in Q4 2025.
  • 180 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on DRW Securities's 13F filing for Q2 2026, filed 14 Aug 2026.